Medicines360 names new vice president of Development and Manufacturing
20 July 2020 -

US-based Medicines360 has named Rolf Jansen as its new vice president of Development and Manufacturing, it was reported on 17 July 2020.

Jansen has over three decades of pharmaceutical experience at firms including Relypsa, KindredBio, Johnson & Johnson and ALZA.

In the new role, Jansen is to head the company's development of medicines aimed at essential women's health products that are facing drug shortages or have high prices affecting availability. He will be responsible for managing and implementing the company's manufacturing and development strategy.